Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
QuintilesIMS
McKinsey
Argus Health
UBS
Cerilliant
US Army
Queensland Health
Healthtrust

Generated: April 22, 2018

DrugPatentWatch Database Preview

Claims for Patent: 8,501,818

« Back to Dashboard

Summary for Patent: 8,501,818
Title:Stabilized compositions of alkylating agents and methods of using same
Abstract: Provided are stable compositions comprising alkylating agents, including nitrogen mustards, that are suitable for topical use, and methods for treating skin disorders comprising topically administering the compositions.
Inventor(s): Alonso; Robert (Rye, NH), Stogniew; Martin (Blue Bell, PA), Crooks; Peter A. (Nicholasville, KY), Pimley; Mark A. (Westchester, PA), Worthen; David R. (Wakefield, RI)
Assignee: Ceptaris Therapeutics, Inc. (Malvern, PA)
Application Number:12/687,605
Patent Claims: 1. A topical composition comprising: (a) an effective amount of bis-(2-chloroethyl)methylamine or a pharmaceutically acceptable salt or solvate thereof; and (b) a pharmaceutically acceptable excipient comprising a compound of the formula HOCH.sub.2CH.sub.2OCH.sub.2CH.sub.2OR.sub.79, wherein R.sub.79 is a linear alkyl group having 1-6 carbon atoms, wherein at least about 90% of the bis-(2-chloroethyl)methylamine or pharmaceutically acceptable salt or solvate thereof is present in the composition after storage for at least about 3 months to about 3 years at a temperature of about -20.degree. C. to about 8.degree. C.

2. The composition of claim 1, wherein at least about 90% of the bis-(2-chloroethyl)methylamine or pharmaceutically acceptable salt or solvate thereof is present in the composition after storage for at least about 3 months to about 3 years at a temperature of about 2.degree. C. to about 8.degree. C.

3. The composition of claim 1, wherein at least about 90% of the bis-(2-chloroethyl)methylamine or pharmaceutically acceptable salt or solvate thereof is present in the composition after storage for at least about 6 months to about 3 years at a temperature of about 2.degree. C. to about 8.degree. C.

4. The composition of claim 1, wherein at least about 90% of the bis-(2-chloroethyl)methylamine or pharmaceutically acceptable salt or solvate thereof is present in the composition after storage for at least about 12 months to about 3 years at a temperature of about 2.degree. C. to about 8.degree. C.

5. The composition of claim 1, wherein at least about 90% of the bis-(2-chloroethyl)methylamine or pharmaceutically acceptable salt or solvate thereof is present in the composition after storage for at least about 24 months to about 3 years at a temperature of about 2.degree. C. to about 8.degree. C.

6. The composition of claim 1, wherein at least about 90% of the bis-(2-chloroethyl)methylamine or pharmaceutically acceptable salt or solvate thereof is present in the composition after storage for at least about 3 months to about 3 years at a temperature of about -20.degree. C. to about -10.degree. C.

7. The composition of claim 1, wherein at least about 90% of the bis-(2-chloroethyl)methylamine or pharmaceutically acceptable salt or solvate thereof is present in the composition after storage for at least about 6 months to about 3 years at a temperature of about -20.degree. C. to about -10.degree. C.

8. The composition of claim 1, wherein at least about 90% of the bis-(2-chloroethyl)methylamine or pharmaceutically acceptable salt or solvate thereof is present in the composition after storage for at least about 12 months to about 3 years at a temperature of about -20.degree. C. to about -10.degree. C.

9. The composition of claim 1, wherein at least about 90% of the bis-(2-chloroethyl)methylamine or pharmaceutically acceptable salt or solvate thereof is present in the composition after storage for at least about 24 months to about 3 years at a temperature of about -20.degree. C. to about -10.degree. C.

10. A topical composition comprising: (a) an effective amount of bis-(2-chloroethyl)methylamine or a pharmaceutically acceptable salt or solvate thereof; and (b) a pharmaceutically acceptable excipient comprising a compound of the formula HOCH.sub.2CH.sub.2OCH.sub.2CH.sub.2OR.sub.79, wherein R.sub.79 is a linear alkyl group having 1-6 carbon atoms, wherein the composition contains less than about 10% by weight of nitrogen mustard degradation product after storage for about 3 months to about 3 years at a temperature of about -20.degree. C. to about 8.degree. C.

11. The composition of claim 10, wherein the nitrogen mustard degradation product is a half-mustard.

12. The composition of claim 11, wherein the half-mustard has the following structure (DP-B): ##STR00061## wherein: E is --O--, --NH--, --S--; --OC(O)CH(CH.sub.3)OC(O)CH(CH.sub.3)-; --OCH(CH.sub.3)C(O)OCH(CH.sub.3)-; or --O(CH.sub.2).sub.20(CH.sub.2).sub.20-; and R.sup.80 is a linear or branched alkyl group having 1-12 carbon atoms, --COOH, or --OH.

13. The composition of claim 10, wherein the nitrogen mustard degradation product is ##STR00062##

14. The composition of claim 10, wherein the nitrogen mustard degradation product is ##STR00063##

15. The composition of claim 10, wherein the nitrogen mustard degradation product is ##STR00064##

16. The composition of claim 10, wherein the composition contains less than about 10% by weight of the nitrogen mustard degradation product after storage for at least about 3 months to about 3 years at a temperature of about 2.degree. C. to about 8.degree. C.

17. The composition of claim 10, wherein the composition contains less than about 10% by weight of the nitrogen mustard degradation product after storage for at least about 6 months to about 3 years at a temperature of about 2.degree. C. to about 8.degree. C.

18. The composition of claim 10, wherein the composition contains less than about 10% by weight of the nitrogen mustard degradation product after storage for at least about 12 months to about 3 years at a temperature of about 2.degree. C. to about 8.degree. C.

19. The composition of claim 10, wherein the composition contains less than about 10% by weight of the nitrogen mustard degradation product after storage for at least about 24 months to about 3 years at a temperature of about 2.degree. C. to about 8.degree. C.

20. The composition of claim 10, wherein the composition contains less than about 10% by weight of the nitrogen mustard degradation product after storage for at least about 3 months to about 3 years at a temperature of about -20.degree. C. to about -10.degree. C.

21. The composition of claim 10, wherein the composition contains less than about 10% by weight of the nitrogen mustard degradation product after storage for at least about 6 months to about 3 years at a temperature of about -20.degree. C. to about -10.degree. C.

22. The composition of claim 10, wherein the composition contains less than about 10% by weight of the nitrogen mustard degradation product after storage for at least about 12 months to about 3 years at a temperature of about -20.degree. C. to about -10.degree. C.

23. The composition of claim 10, wherein the composition contains less than about 10% by weight of the nitrogen mustard degradation product after storage for at least about 24 months to about 3 years at a temperature of about -20.degree. C. to about -10.degree. C.

24. The composition of claim 10, wherein the nitrogen mustard degradation product is: ##STR00065##

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Fish and Richardson
Deloitte
Merck
Medtronic
Queensland Health
Johnson and Johnson
Chinese Patent Office
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.